Cargando…

Inhibition and promotion of tumor growth with adeno-associated virus carcinoembryonic antigen vaccine and Toll like receptor agonists

Carcinoembryonic antigen (CEA) is a cancer vaccines target. Several feature of recombinant adeno-associated virus (rAAV) are attractive for vaccine applications. Combining other viral vector vaccines with Toll like receptor (TLR) agonists enhances antitumor immunity. Wild-type and CEA transgenic (Tg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Triozzi, Pierre L., Aldrich, Wayne, Ponnazhagan, Selvarangan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2011
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4143190/ https://www.ncbi.nlm.nih.gov/pubmed/21869824 http://dx.doi.org/10.1038/cgt.2011.54

Ejemplares similares

Synthetic Biology Design as a Paradigm Shift toward Manufacturing Affordable Adeno-Associated Virus Gene Therapies
por: Collins, Logan Thrasher, et al.
Publicado: (2023)

Effects of Cellular Methylation on Transgene Expression and Site-Specific Integration of Adeno-Associated Virus
por: Chanda, Diptiman, et al.
Publicado: (2017)

Carcinoembryonic Antigen and Smoking
por: Clarke, Cyril, et al.
Publicado: (1980)

Carcinoembryonic Antigen and Smoking
por: Clarke, C. A., et al.
Publicado: (1982)

Myeloid-derived suppressor cells as a novel target for the control of osteolytic bone disease
por: Sawant, Anandi, et al.
Publicado: (2013)

Role of plasmacytoid dendritic cells in breast cancer bone dissemination
por: Sawant, Anandi, et al.
Publicado: (2013)

Application of toll-like receptors (TLRs) and their agonists in cancer vaccines and immunotherapy
por: Chakraborty, Samik, et al.
Publicado: (2023)

Recombinant AAV-CEA Tumor Vaccine in Combination with an Immune Adjuvant Breaks Tolerance and Provides Protective Immunity
por: Hensel, Jonathan A., et al.
Publicado: (2018)

Toll-like receptor 2 agonists inhibit human fibrocyte differentiation
por: Maharjan, Anu S, et al.
Publicado: (2010)

Carcinoembryonic Antigen in Whole Serum
por: MacSween, J. M., et al.
Publicado: (1972)

Carcinoembryonic antigen (CEA) "fingerprints".
por: Rule, A. H., et al.
Publicado: (1973)

Carcinoembryonic antigen in hepatocellular cancer.
por: Macnab, G. M., et al.
Publicado: (1978)

A Carcinoembryonic Antigen-Secreting Adenocarcinoma Arising in Tailgut Cyst : Clinical Implications of Carcinoembryonic Antigen
por: Cho, Byoung Chul, et al.
Publicado: (2005)

Clinical implication of tissue carcinoembryonic antigen expression in association with serum carcinoembryonic antigen in colorectal cancer
por: Aldilaijan, Abdulmohsin Fawzi, et al.
Publicado: (2023)

Toll-Like Receptor 9 Agonists in Cancer
por: Karapetyan, Lilit, et al.
Publicado: (2020)

Natural toll-like receptor agonists in prophylactic vaccines for dendritic cell activation
por: Peng, Paul, et al.
Publicado: (2015)

Mapping epitope characteristics on carcinoembryonic antigen.
por: Harwood, P. J., et al.
Publicado: (1986)

Carboxyl esterase activity of carcinoembryonic antigen?
por: Thomas, P., et al.
Publicado: (1975)

Carcinoembryonic antigens: alternative splicing accounts for the multiple mRNAs that code for novel members of the carcinoembryonic antigen family
Publicado: (1989)

A monkey antigen crossreacting with carcinoembryonic antigen, CEA.
por: Engvall, E., et al.
Publicado: (1976)

The dual targeting of immunosuppressive cells and oxidants promotes effector and memory T-cell functions against lung cancer
por: Sawant, Anandi, et al.
Publicado: (2014)

Detection of carcinoembryonic-like antigen on melanoma cells by leucocyte-dependent-antibody assays.
por: Morgan, G., et al.
Publicado: (1977)

Combination of the toll like receptor agonist and α-Galactosylceramide as an efficient adjuvant for cancer vaccine
por: Gableh, Fateme, et al.
Publicado: (2016)

Bacterial Protein Toll-Like-Receptor Agonists: A Novel Perspective on Vaccine Adjuvants
por: Kumar, Sudeep, et al.
Publicado: (2019)

Toll-Like Receptor 9 Agonists for Cancer Therapy
por: Melisi, Davide, et al.
Publicado: (2014)

Toll-Like Receptor Agonists as Adjuvants for Allergen Immunotherapy
por: Kirtland, Max E., et al.
Publicado: (2020)

STRUCTURAL STUDIES OF THE MAJOR GLYCOPROTEIN IN PREPARATIONS WITH CARCINOEMBRYONIC ANTIGEN ACTIVITY
por: Terry, William D., et al.
Publicado: (1972)

Characterization of Carcinoembryonic Antigen‐related Antigens in Normal Adult Feces
por: Matsuoka, Yuji, et al.
Publicado: (1990)

First British standard for carcinoembryonic antigen (CEA).
por: Laurence, D. J., et al.
Publicado: (1975)

Association of medullary carcinoma of the thyroid with carcinoembryonic antigen.
por: Ishikawa, N., et al.
Publicado: (1976)

Immunochemical studies of carcinoembryonic antigen (CEA) variants.
por: Ichiki, A. T., et al.
Publicado: (1976)

Carcinoembryonic antigen: characterization of binding with insoluble lectins.
por: Macsween, J. M., et al.
Publicado: (1975)

SPECIFIC CARCINOEMBRYONIC ANTIGENS OF THE HUMAN DIGESTIVE SYSTEM
por: Gold, Phil, et al.
Publicado: (1965)

Assaying Carcinoembryonic Antigens by Normalized Saturation Magnetization
por: Huang, Kai-Wen, et al.
Publicado: (2015)

The Significance of Serum Carcinoembryonic Antigen in Lung Adenocarcinoma
por: Kim, Jae Jun, et al.
Publicado: (2015)

On-Site Detection of Carcinoembryonic Antigen in Human Serum
por: Mahmoudi, Tohid, et al.
Publicado: (2021)

In silico experiment with an-antigen-toll like receptor-5 agonist fusion construct for immunogenic application to Helicobacter pylori
por: Haghighi, Mohamad Ali, et al.
Publicado: (2013)

Isolation and Partial Characterization of Macromolecular Urinary Aggregates Containing Carcinoembryonic Antigen-Like Activity
por: Nery, R., et al.
Publicado: (1974)

Urinary carcinoembryonic antigen (CEA)-like molecules and urothelial malignancy: a clinical appraisal.
por: Coombers, G. B., et al.
Publicado: (1975)

Recent Advances in the Development of Toll-like Receptor Agonist-Based Vaccine Adjuvants for Infectious Diseases
por: Yang, Jing-Xing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3bbdm0nmhudecl4b9u5o08vr1c